PeerVoice Oncology & Haematology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 234 Folge(n) erschienen. Jede Woche gibt es eine neue Folge dieses Podcasts.

Gesamtlänge aller Episoden: 4 days 11 minutes

subscribe
share





Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists


Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists


share







 2021-05-08  26m
 
 

Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?


Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?


share







 2021-05-01  19m
 
 

Is It the Carrot or the Stick? Practical Strategies for Improving Adherence to Antidiabetic Therapy


Is It the Carrot or the Stick? Practical Strategies for Improving Adherence to Antidiabetic Therapy


share







 2021-04-22  25m
 
 

Opportunistic Invasive Fungal Infections: Proactive Diagnosis of Patients at Risk


Opportunistic Invasive Fungal Infections: Proactive Diagnosis of Patients at Risk


share







 2021-03-18  23m
 
 

Metastatic Urothelial Carcinoma: Maintaining Stable Disease


Metastatic Urothelial Carcinoma: Maintaining Stable Disease


share







 2021-03-09  15m
 
 

Complementing Evidence With Expert Experience: Challenging Cases in Paroxysmal Nocturnal Haemoglobinuria


"Complementing Evidence With Expert Experience: Challenging Cases in Paroxysmal Nocturnal Haemoglobinuria "


share







 2021-02-27  43m
 
 

Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments


Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments


share







 2021-02-25  15m
 
 

When Physics Fuses With Medicine: A New Therapeutic Modality for mCRPC


When Physics Fuses With Medicine: A New Therapeutic Modality for mCRPC


share







 2021-02-23  20m
 
 

GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!


GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!


share







 2021-02-18  19m
 
 

Beyond HPIs for Advanced Basal Cell Carcinoma: Exploring the Clinical Implications of New Evidence


Beyond HPIs for Advanced Basal Cell Carcinoma: Exploring the Clinical Implications of New Evidence


share







 2021-01-23  19m